Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Stephens

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|October 3, 2002
Presynaptic internal Ca2+ stores contribute to inhibitory neurotransmitter release onto mouse cerebellar Purkinje cellsScott Bardo, Brian Robertson, Gary J Stephens
Journal of Neurochemistry|June 22, 2013
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemiaVasco Silveirinha, Gary J Stephens, Helena Cimarosti
British Journal of Pharmacology|May 25, 2026
Emerging therapeutic opportunities for psychedelic and related drugsSusan Wonnacott, Gary J Stephens, Trevor Sharp
The Journal of Physiology|June 5, 2013
The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signallingXiaowei Wang, Benjamin J Whalley, Gary J Stephens
Neuronal Signaling|July 28, 2020
SUMOylation and calcium signalling: potential roles in the brain and beyondLeticia Coelho-Silva, Gary J Stephens, Helena Cimarosti
British Journal of Pharmacology|November 29, 2024
Psilocybin as a novel treatment for chronic painTate Askey, Reena Lasrado, Maria Maiarú, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Phorbol ester modulation of Ca2+ channels mediates nociceptive transmission in dorsal horn neuronesLi Yang, Iqbal Topia, Toni Schneider, et al.
The Journal of Physiology|September 2, 2006
Evidence that GABA rho subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cellsVictoria L Harvey, Ian C Duguid, Cornelius Krasel, et al.
Molecular Pharmacology|December 30, 2010
Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellumXiaowei Wang, James G Horswill, Benjamin J Whalley, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated ChannelsEleni Kaisis, Laura J Thei, Gary J Stephens, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|October 3, 2002
Presynaptic internal Ca2+ stores contribute to inhibitory neurotransmitter release onto mouse cerebellar Purkinje cellsScott Bardo, Brian Robertson, Gary J Stephens
Journal of Neurochemistry|June 22, 2013
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemiaVasco Silveirinha, Gary J Stephens, Helena Cimarosti
British Journal of Pharmacology|May 25, 2026
Emerging therapeutic opportunities for psychedelic and related drugsSusan Wonnacott, Gary J Stephens, Trevor Sharp
The Journal of Physiology|June 5, 2013
The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signallingXiaowei Wang, Benjamin J Whalley, Gary J Stephens
Neuronal Signaling|July 28, 2020
SUMOylation and calcium signalling: potential roles in the brain and beyondLeticia Coelho-Silva, Gary J Stephens, Helena Cimarosti
British Journal of Pharmacology|November 29, 2024
Psilocybin as a novel treatment for chronic painTate Askey, Reena Lasrado, Maria Maiarú, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Phorbol ester modulation of Ca2+ channels mediates nociceptive transmission in dorsal horn neuronesLi Yang, Iqbal Topia, Toni Schneider, et al.
The Journal of Physiology|September 2, 2006
Evidence that GABA rho subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cellsVictoria L Harvey, Ian C Duguid, Cornelius Krasel, et al.
Molecular Pharmacology|December 30, 2010
Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellumXiaowei Wang, James G Horswill, Benjamin J Whalley, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated ChannelsEleni Kaisis, Laura J Thei, Gary J Stephens, et al.
Pageof 6